Pillstats
Rx only · Solution · Topical

Clobetasol Propionate

Clobetasol Propionate

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)2590
US makers12 labelers
Packages23
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.053$0.106$0.158$0.211Dec 2025Apr 2026Jul 2026
$0.166
Latest avg · Jul 22, 2026
-10%
Since Dec 17, 2025
12
Active US suppliers
26%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

50K99K149K199K2025 Q12025 Q22025 Q32025 Q42026 Q1
162K
Rx · 2026 Q1
8.4M
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it12 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 11, 2019
    RECALLRecall (Class III): Clobetasol Propionate Topical Solution USP, 0.05% w/w, 50 mL bottle, Manufactured for: Macleods Pharma USA, Inc. Plain…

    Defective Container; complaints of leakage. — Recalling firm: Oxalis Labs — Product was distributed to 4 major distributors in IL, NY, AR, KY who may have further distribute the product throughou…